Small Fiber Neuropathy Market is Projected to Gain Healthy Growth by the Expected launch of Emerging Therapies by Major Companies during the Forecast Period (2018-30)

DelveInsight’s Small Fiber Neuropathy Report delivers an in-depth understanding of the Small Fiber Neuropathy, historical and forecasted epidemiology, and the Small Fiber Neuropathy market trends in the United States EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some Key Highlights from Small Fiber Neuropathy Market Report

• According to a study conducted in the Netherlands, the average minimum prevalence of SFN is 52.95 cases per 100,000. The study also found that prevalence rates of SFN were higher in men than in women, and that rates in elderly patients were higher than in younger patients.
• At a 2-year follow-up, the prevalence of idiopathic SFN (in which no underlying cause can be identified) was about 31% among pure SFN patients.
• Emerging therapy in the SFN market is BIIB074 (Biogen), and others.
• Major Player in the SFN market is Biogen.
• The increase in the number of prevalent cases is a major factor in the market’s growth. The growth of the 7MM market is being fueled by rising prevalence and a thorough understanding of the disease.
• To gain more insights request sample page @ Small Fiber Neuropathy Market Insights

The Small Fiber Neuropathy market report covers existing clinical practices, new drugs, individual therapies’ market share, and current and forecasted Small Fiber Neuropathy market sizes in the 7MM (the United States, the EU5, Germany, Italy, Spain, and France), as well as Japan.

Small Fiber Neuropathy: Disease Overview

Small Fiber Neuropathy is a disease that mostly affects the nervous system and is characterised by intense pain attacks. Small Fiber Peripheral Neuropathy occurs when damage to the peripheral nerves mostly or completely affects the small myelinated ((Aδ) fibres or unmyelinated C fibres. It primarily affects the skin’s small nerve fibres, including those that mediate pain and thermal sensation. Small somatic and autonomic fibres are among the fibre types involved in this operation.

Mutations in the SCN9A or SCN10A genes trigger SFN. Both genes control the development of the alpha subunit of the sodium channel NaV1.7.

Small Fiber Neuropathy Epidemiology Segmentation

• Small Fiber Neuropathy Prevalent Cases
• Small Fiber Neuropathy Age-Specific Cases
• Small Fiber Neuropathy Type-Specific Cases
• Small Fiber Neuropathy Gender-Specific Cases
• Small Fiber Neuropathy Diagnosed and Treatable Cases

Visit for more @ SFN Epidemiology

Small Fiber Neuropathy Treatment Landscape

SFN has no known treatment. Currently, the majority of treatment approaches are symptomatic in nature. The major treatment options for treating neuropathic pain are:

• Anticonvulsants
• Antidepressants
• Opioids
• Topical treatment

Small Fiber Neuropathy Market

The rise in prevalent cases of SFN is driving the therapeutic market. Since a larger number of drugs are gaining special designations by regulatory authorities, recent research on molecular level specifics and potential therapeutic targets is expected to boost expectations for the future market.

New therapy like BIIB074 by the major company Biogen is ready to join the SFN market.

Small Fiber Neuropathy Emerging Therapy and Major Company

• BIIB074: Biogen

To learn more about pipeline therapies and companies visit, SFN Pipeline Therapies and Key Companies

Table of Contents

Know more about report offering @ Small Fiber Neuropathy Market

Related Reports

Small Cell Lung Cancer Market 

DelveInsight’s ‘Small Cell Lung Cancer (SCLC)-Market Insights, Epidemiology and Market Forecast-2030’ report delivers an in-depth understanding of the SCLC, historical and forecasted epidemiology as well as the SCLC market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom) and Japan.

Small lymphocytic lymphoma Market

DelveInsight’s “Small lymphocytic lymphoma – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Small lymphocytic lymphoma, historical and forecasted epidemiology as well as the Small lymphocytic lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Non-Small Cell Lung Cancer Market

DelveInsight’s ‘Non-Small Cell Lung Cancer (NSCLC) – Market Insights, Epidemiology and Market Forecast – 2030’ report delivers an in-depth understanding of the Non-Small Cell Lung Cancer, historical and forecasted epidemiology as well as the Non-Small Cell Lung Cancer market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom), and Japan.

BRAF Mutated Non-small Cell Lung Cancer Market

DelveInsight’s ‘BRAF Mutated Non-small Cell Lung Cancer (NSCLC) -Market Insights, Epidemiology and Market Forecast – 2030’ report delivers an in-depth understanding of the BRAF Mutated NSCLC, historical and forecasted epidemiology as well as the BRAF Mutated NSCLC market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom), and Japan.

Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer Market

DelveInsight’s ‘Cellular-mesenchymal Epithelial Transition Factor (C-Met) Mutated Non-small Cell Lung Cancer (NSCLC) -Market Insights, Epidemiology and Market Forecast – 2030’ report delivers an in-depth understanding of the c-Met Mutated NSCLC, historical and forecasted epidemiology as well as the c-Met Mutated NSCLC market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom), and Japan.

Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer Market

DelveInsight’s ‘Epidermal Growth Factor Receptor-Non Small Cell Lung Cancer (EGFR-NSCLC)-Market Insights, Epidemiology and Market Forecast—2030’ report delivers an in-depth understanding of the EGFR NSCLC, historical and forecasted epidemiology as well as the EGFR NSCLC market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom), and Japan.

Chronic Smell and Flavor Loss Market

DelveInsight’s “Chronic Smell and Flavor Loss – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Chronic smell and flavor loss , historical and forecasted epidemiology as well as the Chronic smell and flavor loss market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Atrial Fibrillation Market

DelveInsight’s “Atrial Fibrillation – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Atrial Fibrillation, historical and forecasted epidemiology as well as the Atrial Fibrillation market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Fibromyalgia Market

DelveInsight’s “Fibromyalgia – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Fibromyalgia, historical and forecasted epidemiology as well as the Fibromyalgia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Palmar Fibromatosis Market

DelveInsight’s “Palmar Fibromatosis Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Palmar Fibromatosis, historical and forecasted epidemiology as well as the Palmar Fibromatosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Get in touch with our Business executive for Competitive Insights, M&A and Due Diligence Services

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance. 

Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Contact Information:

Sandeep Joshi 

info@delveinsight.com 

+1(919)321-6187 

www.delveinsight.com

LinkedIn | Facebook | Twitter